Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;334:273 (10 February), doi:10.1136/bmj.39115.406771.1F
| The first 150 words of the full text of this article appear below. |
There may be several reasons why cervical screening coverage in young women has fallen yet again, including problems with access to appointments with general practitioners, but the new policy not to screen women aged 20-24 can hardly have helped.1 It was announced with the message that screening that age group caused more harm than good, which is unlikely to encourage them to accept their invitations from age 25. Prevalence of carcinoma in situ (CIN3) has increased in women aged 20-24 (figure
), which is consistent with more women in recent birth cohorts starting sexual activity in their mid-teens.
| |||||||||||
Amanda Herbert, consultant histopathologist and cytopathologist1, John H F Smith, consultant histopathologist and cytopathologist2
1 Guy's and St Thomas' NHS Foundation Trust, London SE1 7EH amanda.herbert@kcl.ac.uk , 2 Royal Hallamshire Hospital, Sheffield S10 2JF
Read all Rapid Responses